This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by McGovren, J. P. Articles by Swenberg, J. A. Search for Related Content PubMed PubMed Citation Articles by McGovren, J. P. Articles by Swenberg, J. A.

Chronic Cardiotoxicity Studies in Rabbits with 7-con-O-Methylnogarol, a New Anthracycline Antitumor Agent¹

Research Laboratories, The Upjohn Company, Kalamazoo, Michigan 49001

7-con-O-Methylnogarol (7-OMEN), a new analog of the anthracycline antibiotic, nogalamycin, has chemotherapeutic activity in several experimental mouse tumor systems. As part of the preclinical development of 7-OMEN, the cardiotoxic potential was evaluated in chronically dosed rabbits. Groups of 4 rabbits were dosed twice weekly i.v. with 11 or 33 mg/sq m/week for 12 weeks, 110 sq m/mg/week for 12 or 24 weeks, or 154 mg/sq m/week for 24 weeks to give cumulative doses of 132, 396, 1319, 2640, or 3700 mg/sq m, respectively. Histological studies showed minimal evidence of cardiotoxicity in rabbits which received 1319 mg/sq m or lower doses of 7-OMEN. However, the characteristic anthracycline-induced cardiac lesions (vacuolization, myocytolysis, and fibrosis) were present in mild to marked amounts in 8 of 8 rabbits which received cumulative doses of 2640 or 3700 mg/sq m. One rabbit in the 3700 mg/sq m group exhibited excess pericardial fluid; no other gross symptoms of cardiac toxicity were present. None of the 7-OMEN-treated rabbits died from cardiotoxicity. Four Adriamycin-treated control rabbits died of drug-induced cardiomyopathy and congestive heart failure at 222 to 277 mg/sq m. Thus, 7-OMEN was less than one-fifteenth as potent as was Adriamycin in inducing cardiotoxicity in rabbits.

7-OMEN given at 220 mg/sq m/week for 3 to 4 weeks caused lethal bone marrow depression in 4 of 4 rabbits. At lower doses, 7-OMEN caused a mild to moderate, dose-related, regenerative, macrocytic anemia which was most severe approximately halfway through the 24-week study and then improved despite continuous twice-weekly dosing.

¹ This study was supported in part by Contract NO1-CM-43753 with the Division of Cancer Treatment, National Cancer Institute, Department of Health, Education, and Welfare.

² To whom requests for reprints should be addressed.

³ Present address: Chemical Industry Institute of Toxicology, Research Triangle Park, N. C. 27709.

Received 6/10/79. Accepted 8/24/79.